Kristen Elizabeth Bush PA-C

Recommended Articles

• Sleep Apnea Machines: What's a CPAP?

  Sleep Apnea, a sleeping disorder that causes breathing interruption during sleep, has some serious effects if left untreated. The most common and effective treatment for sleep apnea is the CPAP or Continuous Positive Airway Pressure Therapy which aids patients in breathing when asleep.How does CPAP...

• What Are the Causes and Symptoms of Stomach Cancer?

  Stomach cancer, also known as gastric cancer, refers to the cancer that develops in the lining of the stomach. Of the different types of cancer, cancer that develops in the glandular tissue, called adenocarcinoma, is the most common. Few stomach cancers develop in the connective tissue, like muscles...

• Supporting a Loved One with Fibromyalgia

  Having someone that you love diagnosed with fibromyalgia may be challenging for you for various reasons. Some people find it difficult to process this kind of information, because they are afraid of disease and death in general. There are people who have a difficult time dealing with emotional...

• Breakthrough Research on Facioscapulohumeral Muscular Dystrophy

  A study which was recently published in the Natural Communications journal, outlines a major breakthrough in research around facioscapulohumeral muscular dystrophy, also known as FSHD.The study was performed by the University of Minnesota Medical School. Researchers at the university inserted the...

• Is There an Early Diagnosis Possible in Hyperkalemia?

  The human body is made up of certain minerals, each of which has a role to play to ensure a smooth function of the body. The body is considered healthy and working to its best ability when the prescribed balance of these minerals is maintained. When these minerals are lower or higher than the...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...